247 related articles for article (PubMed ID: 37422021)
1. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
3. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
5. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
6. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.
Wang H; Wang Z; Wang Y; Li X; Yang W; Wei S; Shi C; Qiu J; Ni M; Rao J; Cheng F
J Cell Mol Med; 2021 Aug; 25(15):7381-7394. PubMed ID: 34272822
[TBL] [Abstract][Full Text] [Related]
7. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p.
Hanson A; Piras IS; Wilhelmsen D; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
Cytokine; 2019 Nov; 123():154789. PubMed ID: 31352173
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation.
Gao H; Wang X; Ma H; Lin S; Zhang D; Wu W; Liao Z; Chen M; Ye H; Li Q; Lin M; Li D
Sci Rep; 2022 Dec; 12(1):21199. PubMed ID: 36482069
[TBL] [Abstract][Full Text] [Related]
11. miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1.
Pan W; Wang Y; Zhao C
Scand J Gastroenterol; 2023; 58(11):1335-1343. PubMed ID: 37313731
[TBL] [Abstract][Full Text] [Related]
12. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
13. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
Zhang B; Li H; Li D; Sun H; Li M; Hu H
Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
[TBL] [Abstract][Full Text] [Related]
16. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
[TBL] [Abstract][Full Text] [Related]
17. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
18. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
[TBL] [Abstract][Full Text] [Related]
19. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing.
Liu X; Ma H; Wu R; Wang H; Xu H; Li S; Wang G; Lv G; Niu J
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553468
[TBL] [Abstract][Full Text] [Related]
20. PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of
Liu Q; Zhang Y; Yang S; Wu Y; Wang J; Yu W; Liu Y
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]